Mirae Asset Global Investments Co., Ltd. Cytokinetics Inc Transaction History
Mirae Asset Global Investments Co., Ltd.
- $22.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Cytokinetics Inc stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 4,256 shares of CYTK stock, worth $215,992. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,256
Previous 3,423
24.34%
Holding current value
$215,992
Previous $185,000
21.08%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding CYTK
# of Institutions
405Shares Held
125MCall Options Held
4.6MPut Options Held
2.43M-
Black Rock Inc. New York, NY14.7MShares$745 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$597 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.69MShares$492 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.77MShares$395 Million0.07% of portfolio
-
State Street Corp Boston, MA6.46MShares$328 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.78B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...